Month: May 2021

Alstom 2020/21 full year resultsAlstom legacy fully in line with 2021 guidance, following strong commercial activity, sound project execution, and increased profitability Bombardier Transportation integration fully on track Positive rail market outlook, supported by important stimulus plans worldwide Continued achievements in ESGAll data if not specified are reflecting combined Group vision including Alstom legacy fiscal year 2020/21 and Bombardier Transportation contribution for 2 months (February and March 2021) and are in line with Alstom accounting methods. Definitions are provided at the end of this press release. Organic change is excluding scope and forex effects, representing Alstom legacy performance only compared to fiscal year 2019/20. 11 May 2021 – Between 1 April 2020 and 31 March 2021, Alstom booked €9.1 billion of...

NoHo Partners Plc INTERIM REPORT 11 May 2021 at 8:15 a.m. NOHO PARTNERS PLC INTERIM REPORT 1 JANUARY – 31 MARCH 2021 The first quarter was dominated by strict restrictions and the closure of restaurants – the demand outlook for the summer has improved after the difficult spring NoHo Partners’ business was subject to strict restrictions in the first quarter of 2021 and, following an order issued by the Finnish Government, restaurant operations in Finland were shut down starting from 8 March 2021 in the regions where the COVID-19 pandemic was in the acceleration or community transmission phase. The Group’s turnover in January–March 2021 was MEUR 20.2, which represents a decrease of approximately 60 per cent compared to the corresponding period in 2020. NoHo Partners continued to implement determined adjustment measures to manage the negative...

RED DESERT data of all patients confirm:alfapump DSR is highly effective at managing fluid and sodium balance in diuretic-resistant heart failure patients without need for loop diuretics restoration of diuretic response and improvement in cardio-renal function improvement in diuretic response maintained in long-term follow-upSAHARA DESERT study in heart failure patients with residual congestion to start in Q2 2021 Expanding DSR development programme with short-term DSR therapy Evaluating opportunity for DSR therapy for fluid and sodium removal in renal disease         Conference call with live webcast today at 15:00 CEST / 09:00 am EDTGHENT, Belgium, May 11, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant...

Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal Company’s first NK cell engager selected by Sanofi as drug candidate for development Cash position of €181.7 million¹ as of March 31, 2021MARSEILLE, France, May 11, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its revenue and cash position for the three-month period ending March 31, 2021. “This quarter, we have continued to execute against our strategy, successfully progressing the lacutamab TELLOMAK trial in the mycosis fungoides cohort while also advancing our first NK cell engager with our partner, Sanofi,” said Mondher Mahjoubi, Chief Executive Officer of Innate Pharma. “As we continue to advance our...

Marseille, France, May 11, 2021 (GLOBE NEWSWIRE) —Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal Company’s first NK cell engager selected by Sanofi as drug candidate for development Cash position of €181.7 million1 as of March 31, 2021Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its revenue and cash position for the three-month period ending March 31, 2021. “This quarter, we have continued to execute against our strategy, successfully progressing the lacutamab TELLOMAK trial in the mycosis fungoides cohort while also advancing our first NK cell engager with our partner, Sanofi,” said Mondher Mahjoubi, Chief Executive Officer of Innate Pharma. “As we continue to advance...

In April, the consolidated net profit of LHV Group reached EUR 4.2 million. Within the month, LHV Pank earned EUR 4.3 million in net profit, including EUR 0.5 million from servicing clients related to the United Kingdom branch. The net profit of LHV Varahaldus was EUR 0.2 million in April. The number of bank clients increased by 4,300 in April. Client activity was good, and we could see especially high activity in applications for home loans. Within the month, the LHV loan portfolio increased by EUR 16.5 million, half of which originated from housing loans. Due to the reduction of deposits of deposit platforms, the volume of deposits decreased by a total of EUR 33 million, while the deposits of financial intermediaries and private clients both increased. In April, LHV Finance introduced a refinancing loan to the market, which enables clients...

Amsterdam, May 11, 2021 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announced it has been awarded a SG$26 million (~€16 million) contract by the Land Transport Authority (LTA) in Singapore to provide project management support to supervise the construction of the North-South Corridor (NSC) project. Singapore’s North-South Corridor (NSC) was originally planned as an expressway but has since been reconceptualized to also accommodate Singapore’s longest Transit Priority Corridor (TPC) to help achieve the greener Walk-Cycle-Ride future that is central to the city state’s Land Transport Master Plan 2040 vision. With the goal of supporting active mobility usage to get more people walking and cycling, the corridor will feature dedicated and continuous bus lanes, key...

PRESS RELEASE: 11 May 2021, 07:00 CEST Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ Technology to Unlock Potential in Molecular Surveillance Mechelen, Belgium, 11 May 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has received a EUR 1.4 million grant from VLAIO, the Flanders organization for Innovation & Entrepreneurship, for the ongoing development of a new generation technology that will be deployed on the easy-to-use and fully automated molecular diagnostics platform Idylla™. The VLAIO grant is intended to support the ongoing development of a new Idylla™ technology, which will enable the off-line customization of the Idylla™ cartridge1. The first generation Idylla™ cartridges contain not only the...

EEZY PLC  —  INTERIM REPORT  —  11 MAY 2021 AT 8:00 Eezy Plc‘s Interim Report 1-3/2021: Corona continues, focus on the re-opening society January–March 2021Revenue was EUR 36.6 million (EUR 55.1 million in January–March 2020). EBITDA was EUR 2.8 million (2.8). EBIT was EUR 0.9 million (1.0). Earnings per share was EUR 0.01 (0.02). Continuing corona pandemic continued to decrease business volume.Outlook for 2021 Due to the Corona pandemic, Eezy does not give guidance for year 2021. The goal is to give guidance when visibility improves along the re-opening of the society. Key figures (IFRS)EUR million, unlessotherwise specified 1–3/2021 1–3/2020 1–12/2020Revenue 36.6 55.1 190.6EBITDA 2.8 2.8 13.5EBITDA, % 7.5% 5.1% 7.1%EBIT 0.9 1.0 5.6EBIT, % 2.5% 1.8% 2.9%EPS, undiluted, EUR 0.01 0.02 0.11EPS,...

Press Release Outside trading hours – Regulated information* Brussels, 11 May 2021 (07.00 a.m. CEST)          KBC Group: First-quarter result of 557 million euros Light is starting to appear at the end of the tunnel thanks to the large-scale vaccination rollout that started in the first quarter of 2021. However, the coronavirus pandemic is still far from over and continues to cause human suffering and unprecedented economic upheaval all over the world. From the start of the crisis more than a year ago, we have taken responsibility in safeguarding the health of our staff and customers, while ensuring that services continue to be provided. We have also worked closely with government agencies to support all customers impacted by coronavirus, implementing various measures such as loan deferrals. We have, for example, granted payment...